Oslo, 17 August 2026. The board of directors of Zelluna ASA has issued a notice for an extraordinary general meeting scheduled for 9 September. The meeting will address proposed changes to the company’s board composition. Shareholders will be asked to consider the election of an experienced international executive from the biotechnology sector. At the same time, one current board member will step down from the position. The company has stated that the proposed candidate brings extensive expertise in the biotechnology field gained through international roles. This move is intended to strengthen the board’s capabilities as the company continues its operations. The notice provides details on the agenda items and the procedures for participation. Shareholders are encouraged to review the full documentation ahead of the meeting. The extraordinary general meeting will be conducted in accordance with applicable regulations and the company’s articles of association. Further information regarding the meeting location, time, and voting procedures is included in the official notice distributed to shareholders. The board has emphasized the importance of the proposed changes for the future direction of the organization. No additional agenda items have been specified in the initial announcement. The company continues to operate as a publicly listed entity focused on its core activities in the biotechnology area. Updates will be provided as the meeting date approaches. The process for nominating and electing board members follows standard corporate governance practices. The outgoing board member has served in the role for a defined period, and the transition is described as part of normal board renewal. Shareholders will have the opportunity to ask questions and vote on the resolutions during the meeting. The company maintains transparency by making all relevant materials available through its official channels. This extraordinary general meeting represents a routine step in corporate administration. The proposed new board member is expected to contribute specialized knowledge that aligns with the company’s strategic needs. Details on the candidate’s background are outlined in the meeting materials without disclosing personal identifiers. The board believes the addition will support ongoing development efforts. All participants are reminded to adhere to the meeting protocols. The announcement concludes with contact information for inquiries related to the extraordinary general meeting. Overall, the notice reflects standard procedures for board adjustments in a listed company. The date of 9 September has been selected to allow sufficient time for shareholder review. No other significant corporate events are mentioned in connection with this notice. The company remains committed to its established operational framework while preparing for the upcoming vote. This development is presented in a factual manner to inform stakeholders of the scheduled proceedings.
